In Iran, a decreasing trend began in 2006, suggesting that strategies to reduce CHD might differ from other countries. 5 Medical and surgical treatments, including aspirin, beta-blocker, ACE-inhibitor, Percutaneous coronary intervention, and CABG, are readily and frequently used in Iran.
← all excerpts
Explaining the Decline in Coronary Heart Disease Mortality Rate Using IMPACT Model: Estimation of the Changes in Risk Factors and Treatment Uptake in Iran between 2007 and 2016.
1
—
—